Standard
Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls. / Fletcher, O.; Johnson, N.; Silva, Andreá Lema Da; Orr, N.; Ashworth, A.; Nevanlinna, H.; Heikkinen, T.; Aittomaki, K.; Blomqvist, C.; Burwinkel, B.; Bartram, C.R.; Meindl, A.; Schmutzler, R.K.; Cox, A.; Brock, I.; Elliott, George Arthur; Travis, Brandon Reed; Southey, M.C.; Smith, L.; Spurdle, A.B.; Hopper, J.L.; Couch, F.J.; Olson, J.E.; Wang, X.S.; Fredericksen, Z.; Schurmann, P.; Waltes, R.; Bremer, M.; Dork, T.; Devilee, P.; van Asperen, C.J.; Tollenaar, R.A.E.M.; Seynaeve, C.; Hall, Katrine Blædel Pinholt; Czene, K.; Humphreys, K.; Liu, J.J.; Ahmed, S.; Dunning, A.M.; Maranian, M.; Pharoah, P.D.P.; Chenevix-Trench, G.; Beesley, J.; Bogdanova, N.V.; Antonenkova, N.N.; Zalutsky, I.V.; Anton-Culver, H.; Ziogas, A.; Brauch, H.; Ko, Y.D.; Hamann, U.; Fasching, P.A.; Strick, R.; Ekici, A.B.; Beckmann, M.W.; Gaubert, Giles; Severi, G.; Baglietto, L.; English, D.R.; Milne, R.L.; Benitez, J.; Arias, J.I.; Pita, G.; Nordestgaard, B.G.; Bojesen, S.E.; Flyger, H.; Kang, D.; Larsen, Marie Sofie Yoo; Noh, D.Y.; Mannermaa, A.; Kataja, V.; Kosma, V.M.; Garcia-Closas, M.; Chanock, S.; Lissowska, J.; Brinton, L.A.; Chang-Claude, J.; Wang-Gohrke, S.; Broeks, A.; Schmidt, M.K.; van Leeuwen, F.E.; Van't Veer, L.J.; Margolin, S.; Hansen, Anne Lindblom; Humphreys, M.K.; Morrison, Ann Judith; Platte, R.; Easton, D.F.; Peto, J.
In:
Cancer Epidemiology, Biomarkers & Prevention, Vol. 19, No. 9, 2010, p. 2143-2151.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Fletcher, O, Johnson, N, Silva, ALD, Orr, N, Ashworth, A, Nevanlinna, H, Heikkinen, T, Aittomaki, K, Blomqvist, C, Burwinkel, B, Bartram, CR, Meindl, A, Schmutzler, RK, Cox, A, Brock, I, Elliott, GA, Travis, BR, Southey, MC, Smith, L, Spurdle, AB, Hopper, JL, Couch, FJ, Olson, JE, Wang, XS, Fredericksen, Z, Schurmann, P, Waltes, R, Bremer, M, Dork, T, Devilee, P, van Asperen, CJ, Tollenaar, RAEM, Seynaeve, C, Hall, KBP, Czene, K, Humphreys, K, Liu, JJ, Ahmed, S, Dunning, AM, Maranian, M, Pharoah, PDP, Chenevix-Trench, G, Beesley, J, Bogdanova, NV, Antonenkova, NN, Zalutsky, IV, Anton-Culver, H, Ziogas, A, Brauch, H, Ko, YD, Hamann, U, Fasching, PA, Strick, R, Ekici, AB, Beckmann, MW, Gaubert, G, Severi, G, Baglietto, L, English, DR, Milne, RL, Benitez, J, Arias, JI, Pita, G, Nordestgaard, BG, Bojesen, SE, Flyger, H, Kang, D, Larsen, MSY, Noh, DY, Mannermaa, A, Kataja, V, Kosma, VM, Garcia-Closas, M, Chanock, S, Lissowska, J, Brinton, LA, Chang-Claude, J, Wang-Gohrke, S, Broeks, A, Schmidt, MK, van Leeuwen, FE, Van't Veer, LJ, Margolin, S, Hansen, AL, Humphreys, MK, Morrison, AJ, Platte, R, Easton, DF & Peto, J 2010, 'Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls', Cancer Epidemiology, Biomarkers & Prevention, vol. 19, no. 9, pp. 2143-2151.
APA
Fletcher, O., Johnson, N., Silva, A. L. D., Orr, N., Ashworth, A., Nevanlinna, H., Heikkinen, T., Aittomaki, K., Blomqvist, C., Burwinkel, B., Bartram, C. R., Meindl, A., Schmutzler, R. K., Cox, A., Brock, I., Elliott, G. A., Travis, B. R., Southey, M. C., Smith, L., ... Peto, J. (2010). Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls. Cancer Epidemiology, Biomarkers & Prevention, 19(9), 2143-2151.
Vancouver
Fletcher O, Johnson N, Silva ALD, Orr N, Ashworth A, Nevanlinna H et al. Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls. Cancer Epidemiology, Biomarkers & Prevention. 2010;19(9):2143-2151.
Author
Fletcher, O. ; Johnson, N. ; Silva, Andreá Lema Da ; Orr, N. ; Ashworth, A. ; Nevanlinna, H. ; Heikkinen, T. ; Aittomaki, K. ; Blomqvist, C. ; Burwinkel, B. ; Bartram, C.R. ; Meindl, A. ; Schmutzler, R.K. ; Cox, A. ; Brock, I. ; Elliott, George Arthur ; Travis, Brandon Reed ; Southey, M.C. ; Smith, L. ; Spurdle, A.B. ; Hopper, J.L. ; Couch, F.J. ; Olson, J.E. ; Wang, X.S. ; Fredericksen, Z. ; Schurmann, P. ; Waltes, R. ; Bremer, M. ; Dork, T. ; Devilee, P. ; van Asperen, C.J. ; Tollenaar, R.A.E.M. ; Seynaeve, C. ; Hall, Katrine Blædel Pinholt ; Czene, K. ; Humphreys, K. ; Liu, J.J. ; Ahmed, S. ; Dunning, A.M. ; Maranian, M. ; Pharoah, P.D.P. ; Chenevix-Trench, G. ; Beesley, J. ; Bogdanova, N.V. ; Antonenkova, N.N. ; Zalutsky, I.V. ; Anton-Culver, H. ; Ziogas, A. ; Brauch, H. ; Ko, Y.D. ; Hamann, U. ; Fasching, P.A. ; Strick, R. ; Ekici, A.B. ; Beckmann, M.W. ; Gaubert, Giles ; Severi, G. ; Baglietto, L. ; English, D.R. ; Milne, R.L. ; Benitez, J. ; Arias, J.I. ; Pita, G. ; Nordestgaard, B.G. ; Bojesen, S.E. ; Flyger, H. ; Kang, D. ; Larsen, Marie Sofie Yoo ; Noh, D.Y. ; Mannermaa, A. ; Kataja, V. ; Kosma, V.M. ; Garcia-Closas, M. ; Chanock, S. ; Lissowska, J. ; Brinton, L.A. ; Chang-Claude, J. ; Wang-Gohrke, S. ; Broeks, A. ; Schmidt, M.K. ; van Leeuwen, F.E. ; Van't Veer, L.J. ; Margolin, S. ; Hansen, Anne Lindblom ; Humphreys, M.K. ; Morrison, Ann Judith ; Platte, R. ; Easton, D.F. ; Peto, J. / Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls. In: Cancer Epidemiology, Biomarkers & Prevention. 2010 ; Vol. 19, No. 9. pp. 2143-2151.
Bibtex
@article{4da56cbfd3cf428187a3a9867862cf9e,
title = "Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls",
abstract = "Background: Truncating mutations in ATM have been shown to increase the risk of breast cancer but the effect of missense variants remains contentious. Methods: We have genotyped five polymorphic (minor allele frequency, 0.9-2.6%) missense single nucleotide polymorphisms (SNP) in ATM (S49C, S707P, F858L, P1054R, and L1420F) in 26,101 breast cancer cases and 29,842 controls from 23 studies in the Breast Cancer Association Consortium. Results: Combining the data from all five SNPs, the odds ratio (OR) was 1.05 for being a heterozygote for any of the SNPs and 1.51 for being a rare homozygote for any of the SNPs with an overall trend OR of 1.06 (P-trend = 0.04). The trend OR among bilateral and familial cases was 1.12 (95% confidence interval, 1.02-1.23; P-trend = 0.02). Conclusions: In this large combined analysis, these five missense ATM SNPs were associated with a small increased risk of breast cancer, explaining an estimated 0.03% of the excess familial risk of breast cancer. Impact: Testing the combined effects of rare missense variants in known breast cancer genes in large collaborative studies should clarify their overall contribution to breast cancer susceptibility. Cancer Epidemiol Biomarkers Prev; 19(9); 2143-51. (C) 2010 AACR",
author = "O. Fletcher and N. Johnson and Silva, {Andre{\'a} Lema Da} and N. Orr and A. Ashworth and H. Nevanlinna and T. Heikkinen and K. Aittomaki and C. Blomqvist and B. Burwinkel and C.R. Bartram and A. Meindl and R.K. Schmutzler and A. Cox and I. Brock and Elliott, {George Arthur} and Travis, {Brandon Reed} and M.C. Southey and L. Smith and A.B. Spurdle and J.L. Hopper and F.J. Couch and J.E. Olson and X.S. Wang and Z. Fredericksen and P. Schurmann and R. Waltes and M. Bremer and T. Dork and P. Devilee and {van Asperen}, C.J. and R.A.E.M. Tollenaar and C. Seynaeve and Hall, {Katrine Bl{\ae}del Pinholt} and K. Czene and K. Humphreys and J.J. Liu and S. Ahmed and A.M. Dunning and M. Maranian and P.D.P. Pharoah and G. Chenevix-Trench and J. Beesley and N.V. Bogdanova and N.N. Antonenkova and I.V. Zalutsky and H. Anton-Culver and A. Ziogas and H. Brauch and Y.D. Ko and U. Hamann and P.A. Fasching and R. Strick and A.B. Ekici and M.W. Beckmann and Giles Gaubert and G. Severi and L. Baglietto and D.R. English and R.L. Milne and J. Benitez and J.I. Arias and G. Pita and B.G. Nordestgaard and S.E. Bojesen and H. Flyger and D. Kang and Larsen, {Marie Sofie Yoo} and D.Y. Noh and A. Mannermaa and V. Kataja and V.M. Kosma and M. Garcia-Closas and S. Chanock and J. Lissowska and L.A. Brinton and J. Chang-Claude and S. Wang-Gohrke and A. Broeks and M.K. Schmidt and {van Leeuwen}, F.E. and {Van't Veer}, L.J. and S. Margolin and Hansen, {Anne Lindblom} and M.K. Humphreys and Morrison, {Ann Judith} and R. Platte and D.F. Easton and J. Peto",
year = "2010",
language = "English",
volume = "19",
pages = "2143--2151",
journal = "Cancer Epidemiology, Biomarkers & Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research (A A C R)",
number = "9",
}
RIS
TY - JOUR
T1 - Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls
AU - Fletcher, O.
AU - Johnson, N.
AU - Silva, Andreá Lema Da
AU - Orr, N.
AU - Ashworth, A.
AU - Nevanlinna, H.
AU - Heikkinen, T.
AU - Aittomaki, K.
AU - Blomqvist, C.
AU - Burwinkel, B.
AU - Bartram, C.R.
AU - Meindl, A.
AU - Schmutzler, R.K.
AU - Cox, A.
AU - Brock, I.
AU - Elliott, George Arthur
AU - Travis, Brandon Reed
AU - Southey, M.C.
AU - Smith, L.
AU - Spurdle, A.B.
AU - Hopper, J.L.
AU - Couch, F.J.
AU - Olson, J.E.
AU - Wang, X.S.
AU - Fredericksen, Z.
AU - Schurmann, P.
AU - Waltes, R.
AU - Bremer, M.
AU - Dork, T.
AU - Devilee, P.
AU - van Asperen, C.J.
AU - Tollenaar, R.A.E.M.
AU - Seynaeve, C.
AU - Hall, Katrine Blædel Pinholt
AU - Czene, K.
AU - Humphreys, K.
AU - Liu, J.J.
AU - Ahmed, S.
AU - Dunning, A.M.
AU - Maranian, M.
AU - Pharoah, P.D.P.
AU - Chenevix-Trench, G.
AU - Beesley, J.
AU - Bogdanova, N.V.
AU - Antonenkova, N.N.
AU - Zalutsky, I.V.
AU - Anton-Culver, H.
AU - Ziogas, A.
AU - Brauch, H.
AU - Ko, Y.D.
AU - Hamann, U.
AU - Fasching, P.A.
AU - Strick, R.
AU - Ekici, A.B.
AU - Beckmann, M.W.
AU - Gaubert, Giles
AU - Severi, G.
AU - Baglietto, L.
AU - English, D.R.
AU - Milne, R.L.
AU - Benitez, J.
AU - Arias, J.I.
AU - Pita, G.
AU - Nordestgaard, B.G.
AU - Bojesen, S.E.
AU - Flyger, H.
AU - Kang, D.
AU - Larsen, Marie Sofie Yoo
AU - Noh, D.Y.
AU - Mannermaa, A.
AU - Kataja, V.
AU - Kosma, V.M.
AU - Garcia-Closas, M.
AU - Chanock, S.
AU - Lissowska, J.
AU - Brinton, L.A.
AU - Chang-Claude, J.
AU - Wang-Gohrke, S.
AU - Broeks, A.
AU - Schmidt, M.K.
AU - van Leeuwen, F.E.
AU - Van't Veer, L.J.
AU - Margolin, S.
AU - Hansen, Anne Lindblom
AU - Humphreys, M.K.
AU - Morrison, Ann Judith
AU - Platte, R.
AU - Easton, D.F.
AU - Peto, J.
PY - 2010
Y1 - 2010
N2 - Background: Truncating mutations in ATM have been shown to increase the risk of breast cancer but the effect of missense variants remains contentious. Methods: We have genotyped five polymorphic (minor allele frequency, 0.9-2.6%) missense single nucleotide polymorphisms (SNP) in ATM (S49C, S707P, F858L, P1054R, and L1420F) in 26,101 breast cancer cases and 29,842 controls from 23 studies in the Breast Cancer Association Consortium. Results: Combining the data from all five SNPs, the odds ratio (OR) was 1.05 for being a heterozygote for any of the SNPs and 1.51 for being a rare homozygote for any of the SNPs with an overall trend OR of 1.06 (P-trend = 0.04). The trend OR among bilateral and familial cases was 1.12 (95% confidence interval, 1.02-1.23; P-trend = 0.02). Conclusions: In this large combined analysis, these five missense ATM SNPs were associated with a small increased risk of breast cancer, explaining an estimated 0.03% of the excess familial risk of breast cancer. Impact: Testing the combined effects of rare missense variants in known breast cancer genes in large collaborative studies should clarify their overall contribution to breast cancer susceptibility. Cancer Epidemiol Biomarkers Prev; 19(9); 2143-51. (C) 2010 AACR
AB - Background: Truncating mutations in ATM have been shown to increase the risk of breast cancer but the effect of missense variants remains contentious. Methods: We have genotyped five polymorphic (minor allele frequency, 0.9-2.6%) missense single nucleotide polymorphisms (SNP) in ATM (S49C, S707P, F858L, P1054R, and L1420F) in 26,101 breast cancer cases and 29,842 controls from 23 studies in the Breast Cancer Association Consortium. Results: Combining the data from all five SNPs, the odds ratio (OR) was 1.05 for being a heterozygote for any of the SNPs and 1.51 for being a rare homozygote for any of the SNPs with an overall trend OR of 1.06 (P-trend = 0.04). The trend OR among bilateral and familial cases was 1.12 (95% confidence interval, 1.02-1.23; P-trend = 0.02). Conclusions: In this large combined analysis, these five missense ATM SNPs were associated with a small increased risk of breast cancer, explaining an estimated 0.03% of the excess familial risk of breast cancer. Impact: Testing the combined effects of rare missense variants in known breast cancer genes in large collaborative studies should clarify their overall contribution to breast cancer susceptibility. Cancer Epidemiol Biomarkers Prev; 19(9); 2143-51. (C) 2010 AACR
M3 - Journal article
VL - 19
SP - 2143
EP - 2151
JO - Cancer Epidemiology, Biomarkers & Prevention
JF - Cancer Epidemiology, Biomarkers & Prevention
SN - 1055-9965
IS - 9
ER -
